Rosen Law Firm reminds GeneDx investors of August 3 lead plaintiff deadline

GlobeNewswire··Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Rosen Law Firm reminds purchasers of GeneDx Holdings Corp. common stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that GeneDx made false and misleading statements about the impact of its Fabric acquisition on the company's overall business, causing investors to suffer damages when the truth emerged. Investors who purchased shares during the class period may be entitled to compensation through a contingency fee arrangement without out-of-pocket costs. A lead plaintiff must move the Court no later than August 3, 2026.

Impact on assets 1

Biotech & Genomic Medicine▼
GeneDx Holdings Corp.
WGS
▼ NegativeRegulationrelevance

Securities class action lawsuit alleging false statements about Fabric acquisition impact